BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20668670)

  • 21. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
    Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
    J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins.
    Jang B; Shin HY; Choi JK; Nguyen du PT; Jeong BH; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
    J Neuropathol Exp Neurol; 2011 Feb; 70(2):116-24. PubMed ID: 21343880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone Citrullination Represses MicroRNA Expression, Resulting in Increased Oncogene mRNAs in Somatolactotrope Cells.
    DeVore SB; Young CH; Li G; Sundararajan A; Ramaraj T; Mudge J; Schilkey F; Muth A; Thompson PR; Cherrington BD
    Mol Cell Biol; 2018 Oct; 38(19):. PubMed ID: 29987187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
    J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small molecule activates citrullination through targeting PAD2.
    Zhang X; Shen M; Zhu H; Zhang J; Yang M; Su K; Zhang Y; Fu W; Ke X; Qu Y
    Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220248. PubMed ID: 37778388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
    van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
    Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Peptidylarginine Deiminase in the Salivary Glands of
    Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E
    J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
    Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
    Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer's disease brains.
    Ishigami A; Masutomi H; Handa S; Nakamura M; Nakaya S; Uchida Y; Saito Y; Murayama S; Jang B; Jeon YC; Choi EK; Kim YS; Kasahara Y; Maruyama N; Toda T
    J Neurosci Res; 2015 Nov; 93(11):1664-74. PubMed ID: 26190193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.
    Jang B; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
    Prion; 2013; 7(1):42-6. PubMed ID: 23022892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
    Wang Y; Chen R; Gan Y; Ying S
    Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis.
    Wizeman JW; Mohan R
    Biochem Biophys Res Commun; 2017 May; 487(1):134-139. PubMed ID: 28400047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain.
    Shimada N; Handa S; Uchida Y; Fukuda M; Maruyama N; Asaga H; Choi EK; Lee J; Ishigami A
    J Neurosci Res; 2010 Mar; 88(4):798-806. PubMed ID: 19830834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
    Vossenaar ER; Radstake TR; van der Heijden A; van Mansum MA; Dieteren C; de Rooij DJ; Barrera P; Zendman AJ; van Venrooij WJ
    Ann Rheum Dis; 2004 Apr; 63(4):373-81. PubMed ID: 15020330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4).
    Hollingsworth TJ; Radic MZ; Beranova-Giorgianni S; Giorgianni F; Wang Y; Iannaccone A
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3808-3815. PubMed ID: 30073354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.
    U KP; Subramanian V; Nicholas AP; Thompson PR; Ferretti P
    Biochim Biophys Acta; 2014 Jun; 1843(6):1162-71. PubMed ID: 24607566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
    Inal JM; Hristova M; Lange S
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.
    Wang S; Wang Y
    Biochim Biophys Acta; 2013 Oct; 1829(10):1126-35. PubMed ID: 23860259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptidylarginine deiminase 2 regulates expression of DGCR8 affecting miRNA biogenesis in gonadotrope cells.
    Ralston BA; Khan L; DeVore SB; Bronnenberg TA; Flock JW; Sequoia AO; Thompson PR; Navratil AM; Cherrington BD
    Reproduction; 2023 Aug; 166(2):125-134. PubMed ID: 37310889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.